Dronabinol Solid Dosage Packaging for Room-Temperature Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Dronabinol compositions, particularly in oral solid dosage forms, lack stability at room temperature, necessitating refrigerated storage, which is burdensome for vendors and patients.

Innovation Solution

Packaging dronabinol oral solid dosage forms with a separate oxygen scavenger in a container to prevent oxidative degradation and increase shelf life.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If dronabinol is stored at room temperature, then ease of operation is improved, but stability deteriorates

Engineering Contradiction:
Improveease of storageVSAvoidstability
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

An oxygen scavenger is introduced as an intermediary substance in the packaging system to remove oxygen from the container headspace. This mediator prevents direct contact between oxygen and dronabinol, thereby maintaining stability at room temperature without requiring refrigeration.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The packaging system creates an inert atmosphere by using an oxygen scavenger to eliminate oxygen from the container environment. This transforms the storage environment from an oxygen-containing atmosphere that promotes degradation to an oxygen-free inert atmosphere that preserves dronabinol stability at room temperature.

Inventive Principle:
Principle #39Inert atmosphere (Inert environment)

2Stability of the object's composition

If refrigerated storage is used, then stability is improved, but device complexity increases

Engineering Contradiction:
ImprovestabilityVSAvoidstorage requirements
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

The oxygen scavenger serves as a chemical intermediary that actively removes oxygen from the packaging headspace. This mediator enables room temperature storage by preventing oxidative degradation, thereby eliminating the need for complex refrigerated storage infrastructure.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The packaging system changes the chemical parameter of the storage environment by using an oxygen scavenger to reduce oxygen concentration to near-zero levels. This parameter change (from ambient oxygen levels to oxygen-free conditions) allows stability at room temperature, removing the need for temperature-controlled storage.

Inventive Principle:
Principle #35Parameter changes

3Stability of the object's composition

If oxygen is present in packaging, then oxidative degradation occurs, but removing oxygen increases packaging complexity

Engineering Contradiction:
ImprovestabilityVSAvoidpackaging system
Core Design Contradiction:
Stability of the object's compositionVSDevice complexity

Solution Approach 1:

An oxygen scavenger packet or canister is placed inside the container as an intermediary oxygen-removing agent. This simple additive component absorbs residual oxygen in the headspace without requiring complex vacuum sealing or inert gas filling systems, thus maintaining stability while minimizing packaging complexity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The oxygen scavenger is implemented as a disposable, single-use component (packet or canister) that is inexpensive and simple in design. This short-living oxygen-absorbing element provides effective oxygen removal during the product shelf life without requiring complex reusable oxygen-exclusion systems.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The packaging system maintains dronabinol stability at room temperature for extended periods, reducing the need for refrigeration and minimizing impurities.

Implementation Method 1

retarding or preventing oxidative degradation of a dronabinol oral solid dosage form

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS20250360084A1Systems and methods for increasing stability of dronabinol compositions
Publication Date: 2025.11.27 RHODES TECHNOLOGIES INC
  • US20250360084A1 patent drawing

AI summary

Disclosed in certain embodiments is a system and method of providing a dronabinol oral solid dosage form with increased stability.